Showing results (141-150 of 168) with videos related to
Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLCGonzalo Recondo, Magda Bahcall, Liam F Spurr, et al.JTO Clinical and Research Reports|July 21, 2025
A Phase II Study of Cabozantinib in Patients With MET-Altered Lung CancersGuilherme Harada, Fernando C Santini, Clare J Wilhelm, et al.Biorxiv : the Preprint Server for Biology|October 9, 2023
Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinomaZhuxuan Li, Xueqian Zhuang, Chun-Hao Pan, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2022
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLCMarina K Baine, Christopher A Febres-Aldana, Jason C Chang, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 30, 2019
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indicesNatasha Rekhtman, Patrice Desmeules, Anna M Litvak, et al.Nature Communications|November 23, 2022
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologiesYonina R Murciano-Goroff, Alison M Schram, Ezra Y Rosen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2022
Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient SubsetChristopher A Febres-Aldana, Jason C Chang, Ryan Ptashkin, et al.Annals of the American Thoracic Society|February 21, 2026
The Complementary Roles of EBUS-Guided Needle Aspiration, Mini-Forceps, and Cryobiopsy in the Investigation of Mediastinal LesionsOr Kalchiem-Dekel, Brie E Kezlarian-Sachs, Xiaoyue Ma, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung CancerAdam J Schoenfeld, Joseph M Chan, Daisuke Kubota, et al.JCO Precision Oncology|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung CancerN Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.Pageof 17